Menactra/Meningococcal › Services
Menactra vaccine is a safe and effective vaccine against meningococcal disease. Although rare, meningococcal disease is a serious bacterial illness that includes meningitis (the inflammation of the protective layer surrounding the brain and spinal cord) and septicemia (blood poisoning). Between 1000 and 2600 cases of meningococcal disease occur in the United States annually. Every year, the disease quickly ends the lives of children and can leave its survivors permanently disabled. Fortunately, you’re not powerless. Menactra vaccine can help.
Menactra vaccine helps protect children
- Menactra vaccine works. A single shot can help prevent your child from getting meningococcal disease, which includes meningitis.
- Menactra vaccine protects. It’s an effective defense against the most common strains of the meningitis bacteria (A, C, Y, and W-135) in the United States.
- Menactra vaccine is safe. Serious side effects are very rare.
- The Centers for Disease Control and Prevention (CDC) recommends a meningococcal vaccine like Menactra for children 11 through 18 years of age.
- Menactra vaccine is manufactured and distributed by Sanofi Pasteur Inc., a company with a long history of firsts, including one of the first meningococcal meningitis vaccines, a quadrivalent polysaccharide vaccine, and now Menactra vaccine, the first and only quadrivalent conjugate vaccine licensed in the United States for the prevention against certain strains of meningococcal disease.
Taken from www.menactra.com